Pediatric Hepatic Tumors

Launched by GUSTAVE ROUSSY, CANCER CAMPUS, GRAND PARIS · Feb 17, 2020

Keywords

ClinConnect Summary

**Summary of the Pediatric Hepatic Tumors Clinical Trial**

This clinical trial is studying liver tumors in children and adolescents, focusing on collecting biological samples like tissue and blood from patients diagnosed with these tumors. The goal is to create a comprehensive database that helps researchers understand how to better diagnose and treat liver tumors in young patients. The trial is currently recruiting participants across France, and it welcomes children and teenagers who were diagnosed with a primary liver tumor after January 1, 1990, and received treatment in France.

To join the trial, participants must be 18 years old or younger at the time of their diagnosis, and their parents or guardians must provide consent for their data and biological samples to be used. Importantly, there are no specific exclusions, meaning most children with liver tumors may qualify. If you or your child participate, you will be contributing valuable information to help improve future care for children facing similar challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• 1. - For inclusion in the clinical database:
• • Children and adolescents (≤18 years at diagnosis) suffering from a primary liver tumor diagnosed after 01/01/1990 and treated in France
• • Informed consent to the computerization of data signed by the patient or by parents or legal representatives if he is a minor.
• 2. - For inclusion in the biological collection (CRB Paris Sud):
• * Additional criteria:
• • Availability of biological samples (tumor tissue, healthy tissue, plasma and / or serum).
• • Informed consent to the use of biological remains signed by the patient or by parents or legal representatives if he is a minor.
• 3. - For the inclusion of deceased patients:
• • Obtaining consent or failing this, seeking non-opposition to the computerization of data (for inclusion in the database) and the use of biological remains (for inclusion in the biological collection) of the patient or both parents or the legal guardian if he is a minor.
• Exclusion Criteria:
• • None